Neurol. praxi. 2016;17(6):402-407 | DOI: 10.36290/neu.2016.084

Pitfalls of prodromal phase of herpes zoster and experience with pregabalin

MUDr. Irena Bednářová
Neurologické odd., Nemocnice a.s. Jindřichův Hradec

Pain as the most significant clinical symptom of herpes zoster (HZ, shingles) is classified as neuropathic pain. In the acute phase of skin eruption, it is referred to as herpetic neuralgia (HN). Pain, however, can occur as early as the pre-eruptive phase wherein various painful symptoms may be misdiagnosed, depending on the location, as a number of other conditions (e.g., ulcerous disease, renal colic, lumbar ischialgia, myocardial infarction, and others). If acute pain progresses to a chronic stage, it is referred to as post-herpetic neuralgia (PHN) the treatment of which is often very difficult. The case report presents a female patient with an unusually long prodromal phase of the disease as well as evaluates the effect of very early commencement of treatment for neuropathic pain with pregabalin, an adjuvant analgesic, both in terms of the relationship to acute HN and affecting the development of PHN.

Keywords: herpetic neuralgia, prodromal phase, neuropathic pain, pregabalin

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bednářová I. Pitfalls of prodromal phase of herpes zoster and experience with pregabalin. Neurol. praxi. 2016;17(6):402-407. doi: 10.36290/neu.2016.084.
Download citation

References

  1. Ambler Z. Herpes zoster a postherpetická neuralgie: prevence a léčba - komentář. Medicína po promoci. 2011; 12(6): 40-42. na WWW: <http://www.tribune.cz/tituly/mpp/archiv/381.
  2. Ambler Z. Poruchy periferních nervů. Praha: Triton, 2013: 444-454.
  3. Bednařík J. Farmakoterapie neuropatické bolesti ve světle medicíny založené na důkazech. Bolest 2014; 17(2): 41-46.
  4. Bednařík J, Ambler Z, Růžička E, Cerman J, Česák T, Ehler E, Eliáš P, Havrdová E, Herman E, Hobza V, Hovorka J, Kadaňka Z, Komárek V, Kuba R, Látr I, Mareš J, Marková J, Marusič P, Mechl M, Náhlovský J, Němeček S, Němečková J, Nevšímalová S, Pícha D, Růžička E, Smrčka M, Štourač P, Urban P, Voháňka S, Vymazal J. Klinická neurologie: část speciální I. 2010. Praha: Triton, 2010: 481.
  5. Bricout H, Perinetti E, Marchettini P, Ragni P, Zotti CM, Gabutti G, Volpi A, Franco E. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study. BMC Infect Dis. 2014 Dec 6; 14 (1): 637. Dostupné na WWW: <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268902/. Go to original source... Go to PubMed...
  6. Ehler E. Farmakologický profil pregabalinu (Lyrica). Neurol. praxi 2014; 6: 350-354.
  7. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002; 347(5): 340-346. Go to original source... Go to PubMed...
  8. Jensen-Dahm C, Rowbotham MC, Reda H, Petersen KL. Effect of a single dose of pregabalin on herpes zoster pain. Trials. 2011 Feb 28; 12: 55. doi: 10,1186 / 1745-6215-12-55. Dostupné na WWW: <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059274/. Go to original source... Go to PubMed...
  9. Opavský J. Neuropatické bolesti - patofyziologické mechanizmy a principy terapie. Neurol. praxi 2006; 5: 270-274.
  10. Růžičková Jarešová L. Varicella, herpes zoster, komplikace a postherpetické neuralgie, prevence. Neurol. praxi 2015; 16(5): 290-292.
  11. Smetana J, Salavec M, Boštíková V, Chlíbek R, Boštík P, Hanovcová I, Vacková M, Matulková P, Špliňo M. Epidemiol. Mikrobiol. Imunol. 2010; 59(3): 138-146. Go to PubMed...
  12. Švestka J, Doležel T. Pregabalin - nové nebenzodiazepinové anxiolytikum. Psychiatrie, Praha: TIGIS s.r.o., 2007; 11(1): 24-30.
  13. Vondráčková D. Pásový opar a postherpetická neuralgie. PM 2003; 1. Dostupné z WWW: http://zdravi.euro.cz/clanek/postgradualni-medicina/pasovy-opar-a-postherpeticka-neuralgie-151982.
  14. Watson P. Postherpetic neuralgia (updated). Clin Evid (Online). October 8, 2010. Accessed February 7, 2011. Dostupné na WWW: <http://clinicalevidence.bmj.com/x/systematic-review/0905/overview.html




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.